We do not support your browser. Please take a moment and upgrade to the most recent version of Internet Explorer.

A General Model for Oncogenic Activation of ERK with Therapeutic Implications - Neal Rosen, M.D., Ph.D., Memorial Sloan Kettering Cancer Center

Type: Seminar Series


Neal Rosen, M.D., Ph.D.
Director, Center for Mechanism-Based Therapeutics
Member, Program in Molecular Pharmacology
Memorial Sloan Kettering Cancer Center
Professor of Pharmacology and Medicine, Cornell University

DGSOM Theme: Cancer

Lunch is provided. 

Co-sponsored by the UCLA David Geffen School of Medicine Themes

For additional information, please contact:

Return to Announcements & Events Listings